Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Signs Letter of Intent with Large Multinational Pharmaceutical Company (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

Healthcare Cannabis Cannabis
MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes,... see more

TSX:LABS - Post Discussion

Medipharm Labs Corp > 2022
View:
Post by allibabba on Dec 17, 2021 3:05pm

2022

Well folks, it's been a looooong 3 years for me.  It may be obvious but I'm calling a bottom.  Let's hope 2022 brings a much deserved turn around for longs.  I'm going to say buyout in the 80 cent range midway through next year.  Just a guess....GLTA
Comment by mcamm10 on Dec 17, 2021 3:15pm
This post has been removed in accordance with Community Policy
Comment by Solid1 on Dec 18, 2021 6:41am
maybe it has something to do with that it is from a prospectus from February 2021 in this period also the results for phase 1 were published. the Q3 is already long gone, but this could also mean that there could be an announcement every day.  Unique Cannabinoid Purification The Company currently purifies unique cannabinoids from natural sources. Current activities are small scale and used ...more  
Comment by mcamm10 on Dec 18, 2021 9:08am
This post has been removed in accordance with Community Policy
Comment by mcamm10 on Dec 18, 2021 9:20am
This post has been removed in accordance with Community Policy
Medipharm Labs Corp
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities